Evidence map›Paper›PMID 29520270›Full record

ArticleFrontiers in immunology2018

A Novel Role for C5a in B-1 Cell Homeostasis.

Katharina Bröker, Julia Figge, Albert F Magnusen, Rudolf A Manz, Jörg Köhl, Christian M Karsten

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Complement C1r serine protease contributes to kidney fibrosis.American journal of physiology. Renal physiology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Katharina BrökerBrandenburg Medical School, University Hospital Brandenburg, Center of Internal Medicine II, Brandenburg a. d. Havel, Germany.
Julia FiggeInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Albert F MagnusenDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Rudolf A ManzInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Jörg KöhlInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Christian M KarstenInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
University of Lübeck · DECincinnati Children's Hospital Medical Center · USKlinikum Brandenburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-1 cells constitute a unique subpopulation of lymphocytes residing mainly in body cavities like the peritoneal cavity (PerC) but are also found in spleen and bone marrow (BM). As innate-like B cells, they mediate first line immune defense through low-affinity natural IgM (nIgM) antibodies. PerC B-1 cells can egress to the spleen and differentiate into nIgM antibody-secreting plasma cells that recognize conserved exogenous and endogenous cellular structures. Homing to and homeostasis within the PerC are regulated by the chemokine CXCL13 released by PerC macrophages and stroma cells. However, the exact mechanisms underlying the regulation of CXCL13 and B-1 homeostasis are not fully explored. B-1 cells play important roles in the inflammatory response to infection, autoimmunity, ischemia/reperfusion injury, obesity, and atherosclerosis. Remarkably, this list of inflammatory entities has a strong overlap with diseases that are regulated by complement suggesting a link between B-1 cells and the complement system. Interestingly, up to now, no data exist regarding the role of complement in B-1 cell biology. Here, we demonstrate for the first time that C5a regulates B-1 cell steady-state dynamics within the peritoneum, the spleen, and the BM. We found decreased B-1a cell numbers in the peritoneum and the spleen of C5aR1

Indexed as

AnimalsB-LymphocytesB-Lymphocyte SubsetsCells, CulturedChemokine CXCL13Complement C5aCytokinesHomeostasisHumansImmunity, InnateImmunoglobulin MLymphocyte ActivationMacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLC5ar1 protein, mouseC5ar2 protein, mouseChemokine CXCL13Complement C5aCxcl13 protein, mouseCytokinesImmunoglobulin MReceptor, Anaphylatoxin C5aReceptors, Interleukin-10B-1 cellsC5C5acomplementCXCL13natural antibodies

Identifiers

PMID29520270
PMCPMC5827565
OpenAlexW2790161370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.